Anticancer Activity of Nicotinamide on Lung Cancer
NCT02416739
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
110
Enrollment
OTHER
Sponsor class
Conditions
Non-Small-Cell Lung Carcinoma
Interventions
DRUG:
Nicotinamide
Sponsor
Il Yeong Park, Ph.D.